Allied Healthcare Products Inc. (AHPI) and AxoGen Inc. (NASDAQ:AXGN) Contrasting side by side

Allied Healthcare Products Inc. (NASDAQ:AHPI) and AxoGen Inc. (NASDAQ:AXGN) are two firms in the Medical Appliances & Equipment that compete against each other. Below is a comparison of their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation.

Valuation & Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Allied Healthcare Products Inc. 32.37M 0.23 1.78M -0.39 0.00
AxoGen Inc. 89.96M 9.11 26.26M -0.60 0.00

Table 1 shows the gross revenue, earnings per share (EPS) and valuation for Allied Healthcare Products Inc. and AxoGen Inc.

Profitability

Table 2 provides us Allied Healthcare Products Inc. and AxoGen Inc.’s return on equity, net margins and return on assets.

Net Margins Return on Equity Return on Assets
Allied Healthcare Products Inc. -5.50% 0% 0%
AxoGen Inc. -29.19% -19.1% -16.7%

Risk and Volatility

Allied Healthcare Products Inc. has a 0.19 beta, while its volatility is 81.00% which is less volatile than Standard and Poor’s 500. In other hand, AxoGen Inc. has beta of 0.14 which is 86.00% less volatile than Standard and Poor’s 500.

Liquidity

The Current Ratio and Quick Ratio of Allied Healthcare Products Inc. are 2.4 and 0.8 respectively. Its competitor AxoGen Inc.’s Current Ratio is 11.6 and its Quick Ratio is 10.7. AxoGen Inc. can pay off short and long-term obligations better than Allied Healthcare Products Inc.

Analyst Recommendations

The table given features the ratings and recommendations for Allied Healthcare Products Inc. and AxoGen Inc.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Allied Healthcare Products Inc. 0 0 0 0.00
AxoGen Inc. 0 0 3 3.00

Meanwhile, AxoGen Inc.’s consensus price target is $29.67, while its potential upside is 41.76%.

Insider & Institutional Ownership

The shares of both Allied Healthcare Products Inc. and AxoGen Inc. are owned by institutional investors at 11.3% and 90.5% respectively. Insiders owned 2.3% of Allied Healthcare Products Inc. shares. Competitively, 2.7% are AxoGen Inc.’s share owned by insiders.

Performance

In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Allied Healthcare Products Inc. -6.55% -6.11% -14.08% -25% -22.5% -3.11%
AxoGen Inc. 11.58% 22.06% -37.63% -54.28% -40.68% -1.42%

For the past year AxoGen Inc. has weaker performance than Allied Healthcare Products Inc.

Summary

Allied Healthcare Products Inc. beats AxoGen Inc. on 6 of the 11 factors.

AxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The companyÂ’s surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.